According to ALX Oncology's latest financial reports the company's current EPS (TTM) is -$2.47. In 2024 the company made an earnings per share (EPS) of -$2.60.
Year | EPS | Change |
---|---|---|
2025 (TTM) | -$2.47 | -5% |
2024 | -$2.60 | |
2022 | -$3.03 | 47.09% |
2021 | -$2.06 | 39.49% |
2020 | -$1.48 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | -$1.87 | -24.29% | ๐บ๐ธ USA |